MRS. AVNEET KAUR SODHI-GAUR M.D.
Prescription History 1982929105
Ophthalmology in Lancaster, CA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MRS. AVNEET KAUR SODHI-GAUR M.D., an active Ophthalmology specialist practicing in Lancaster, CA. Our medical registry currently tracks 34 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 2,545 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 393 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other CA PrescribersVs. CA Avg |
|---|---|---|---|
| Latanoprost | 393 | $15.09▼ below CA avg | ▲ More than typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2023, this provider wrote 393 Medicare prescriptions for Latanoprost, about 2.5 times the volume of the typical California prescriber of this medication (159). Medicare paid an average of $15.09 per fill, versus $21.01 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 643.6 30-Day Fills standardized to 30-day supplies 18,172 Days of Medication total across all patients in 2023 | |||
| Timolol Maleate | 233 | $19.59▼ below CA avg | ▲ More than typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2023, this provider wrote 233 Medicare prescriptions for Timolol Maleate, about 10 times the volume of the typical California prescriber of this medication (23). Medicare paid an average of $19.59 per fill, versus $450.88 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 474.9 30-Day Fills standardized to 30-day supplies 14,097 Days of Medication total across all patients in 2023 | |||
| LumiganBimatoprost | 184 | $434.99 | ▲ More than typical |
About Lumigan: Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 184 Medicare prescriptions for Lumigan, about 2.2 times the volume of the typical California prescriber of this medication (82). Medicare paid an average of $434.99 per fill, versus $432.66 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 290.2 30-Day Fills standardized to 30-day supplies 8,112 Days of Medication total across all patients in 2023 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 180 | $32.17▼ below CA avg | ▲ More than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 180 Medicare prescriptions for Dorzolamide-Timolol, about 1.6 times the volume of the typical California prescriber of this medication (115). Medicare paid an average of $32.17 per fill, versus $34.52 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 336.2 30-Day Fills standardized to 30-day supplies 9,921 Days of Medication total across all patients in 2023 | |||
| Alphagan PBrimonidine Tartrate | 155 | $428.41 | ▲ More than typical |
About Alphagan P: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 155 Medicare prescriptions for Alphagan P, about 2.7 times the volume of the typical California prescriber of this medication (58). Medicare paid an average of $428.41 per fill, versus $373.95 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 265 30-Day Fills standardized to 30-day supplies 7,742 Days of Medication total across all patients in 2023 | |||
| Prednisolone Acetate | 146 | $48.86▼ below CA avg | ≈ Typical |
About Prednisolone Acetate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. In 2023, this provider wrote 146 Medicare prescriptions for Prednisolone Acetate, about the same volume as the typical California prescriber of this medication (142). Medicare paid an average of $48.86 per fill, versus $51.41 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 186.5 30-Day Fills standardized to 30-day supplies 4,750 Days of Medication total across all patients in 2023 | |||
| SimbrinzaBrinzolamide/Brimonidine Tart | 136 | $232.23▼ below CA avg | ▲ More than typical |
About Simbrinza: This product contains two medications used to treat high pressure in the eye due to glaucoma (open-angle glaucoma-type) or a certain other eye disease (ocular hypertension). Show more ▾ Lowering high pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This product contains brinzolamide and brimonidine. These two medications work together to decrease the amount of fluid within the eye. Brinzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. Brimonidine belongs to a class of drugs known as alpha agonists. This product is not recommended for use in children younger than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. In 2023, this provider wrote 136 Medicare prescriptions for Simbrinza, about 3.6 times the volume of the typical California prescriber of this medication (38). Medicare paid an average of $232.23 per fill, versus $258.19 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 187.9 30-Day Fills standardized to 30-day supplies 5,531 Days of Medication total across all patients in 2023 | |||
| CombiganBrimonidine Tartrate/Timolol | 126 | $355.02▼ below CA avg | ▲ More than typical |
About Combigan: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2023, this provider wrote 126 Medicare prescriptions for Combigan, about 2.6 times the volume of the typical California prescriber of this medication (49). Medicare paid an average of $355.02 per fill, versus $362.16 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 192.5 30-Day Fills standardized to 30-day supplies 5,451 Days of Medication total across all patients in 2023 | |||
| ProlensaBromfenac Sodium | 98 | $360.87 | ▲ More than typical |
About Prolensa: This medication is used to treat swelling (inflammation) and pain in the eye after a certain type of eye surgery (cataract surgery). Show more ▾ Bromfenac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking the effects of certain natural substances (prostaglandins) that cause pain and inflammation. In 2023, this provider wrote 98 Medicare prescriptions for Prolensa, about 1.4 times the volume of the typical California prescriber of this medication (70). Medicare paid an average of $360.87 per fill, versus $357.23 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 107.2 30-Day Fills standardized to 30-day supplies 2,767 Days of Medication total across all patients in 2023 | |||
| Gatifloxacin | 89 | $48.47▼ below CA avg | ▲ More than typical |
About Gatifloxacin: This medication is a quinolone antibiotic used for eye infections (such as conjunctivitis). Show more ▾ This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS. In 2023, this provider wrote 89 Medicare prescriptions for Gatifloxacin, about 1.8 times the volume of the typical California prescriber of this medication (49). Medicare paid an average of $48.47 per fill, versus $55.71 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 89.3 30-Day Fills standardized to 30-day supplies 1,159 Days of Medication total across all patients in 2023 | |||
| Dorzolamide Hcl | 83 | $30.21▼ below CA avg | ▲ More than typical |
About Dorzolamide Hcl: Dorzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 83 Medicare prescriptions for Dorzolamide Hcl, about 1.5 times the volume of the typical California prescriber of this medication (55). Medicare paid an average of $30.21 per fill, versus $32.79 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 181 30-Day Fills standardized to 30-day supplies 5,427 Days of Medication total across all patients in 2023 | |||
| RestasisCyclosporine | 76 | $749.54▼ below CA avg | ≈ Typical |
About Restasis: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. In 2023, this provider wrote 76 Medicare prescriptions for Restasis, about 89% of the volume of the typical California prescriber of this medication (85). Medicare paid an average of $749.54 per fill, versus $947.95 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 88 30-Day Fills standardized to 30-day supplies 2,640 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate | 74 | $87.91 | ≈ Typical |
About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 74 Medicare prescriptions for Brimonidine Tartrate, about the same volume as the typical California prescriber of this medication (78). Medicare paid an average of $87.91 per fill, versus $43.38 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 163.3 30-Day Fills standardized to 30-day supplies 4,846 Days of Medication total across all patients in 2023 | |||
| RocklatanNetarsudil Mesylat/Latanoprost | 60 | $485.13▼ below CA avg | ▲ More than typical |
About Rocklatan: Netarsudil/latanoprost is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent vision loss or blindness. In 2023, this provider wrote 60 Medicare prescriptions for Rocklatan, about 1.4 times the volume of the typical California prescriber of this medication (44). Medicare paid an average of $485.13 per fill, versus $507.48 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 79.7 30-Day Fills standardized to 30-day supplies 2,108 Days of Medication total across all patients in 2023 | |||
| RhopressaNetarsudil Mesylate | 54 | $382.15▼ below CA avg | ≈ Typical |
About Rhopressa: Netarsudil is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). Show more ▾ This medication is thought to work by increasing the flow of fluid out of the eye. This helps lower pressure inside the eye. Lowering high pressure inside the eye can help prevent loss of vision or blindness. In 2023, this provider wrote 54 Medicare prescriptions for Rhopressa, about the same volume as the typical California prescriber of this medication (54). Medicare paid an average of $382.15 per fill, versus $488.55 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 70 30-Day Fills standardized to 30-day supplies 1,975 Days of Medication total across all patients in 2023 | |||
| Dorzolamide-TimololDorzolamide/Timolol/Pf | 52 | $174.22 | ▼ Less than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 52 Medicare prescriptions for Dorzolamide-Timolol, about half the volume of the typical California prescriber of this medication (115). Medicare paid an average of $174.22 per fill, versus $34.52 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 92 30-Day Fills standardized to 30-day supplies 2,745 Days of Medication total across all patients in 2023 | |||
| Lotemax SmLoteprednol Etabonate | 47 | $256.38▼ below CA avg | ≈ Typical |
About Lotemax Sm: This medication is used to temporarily relieve seasonal allergy symptoms of the eyes such as swelling, redness, and itching. Show more ▾ Loteprednol belongs to a class of drugs known as corticosteroids. An androstadiene derivative corticosteroid that is used as an ANTI-ALLERGIC AGENT for the treatment of inflammatory and allergic eye conditions. In 2023, this provider wrote 47 Medicare prescriptions for Lotemax Sm, about the same volume as the typical California prescriber of this medication (43). Medicare paid an average of $256.38 per fill, versus $267.41 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 50.5 30-Day Fills standardized to 30-day supplies 1,133 Days of Medication total across all patients in 2023 | |||
| Brinzolamide | 39 | $256.47▼ below CA avg | ▲ More than typical |
About Brinzolamide: Brinzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 39 Medicare prescriptions for Brinzolamide, about 1.4 times the volume of the typical California prescriber of this medication (27). Medicare paid an average of $256.47 per fill, versus $338.35 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 62.5 30-Day Fills standardized to 30-day supplies 1,866 Days of Medication total across all patients in 2023 | |||
| TafluprostTafluprost/Pf | 34 | $227.95▼ below CA avg | ≈ Typical |
About Tafluprost: Tafluprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. In 2023, this provider wrote 34 Medicare prescriptions for Tafluprost, about 1.2 times the volume of the typical California prescriber of this medication (29). Medicare paid an average of $227.95 per fill, versus $440.98 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 48 30-Day Fills standardized to 30-day supplies 1,440 Days of Medication total across all patients in 2023 | |||
| ZioptanTafluprost/Pf | 28 | $447.79 | ≈ Typical |
About Zioptan: Tafluprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. In 2023, this provider wrote 28 Medicare prescriptions for Zioptan, about 85% of the volume of the typical California prescriber of this medication (33). Medicare paid an average of $447.79 per fill, versus $378.99 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 50 30-Day Fills standardized to 30-day supplies 1,500 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 24 | $243.51▼ below CA avg | ≈ Typical |
About Brimonidine Tartrate-Timolol: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2023, this provider wrote 24 Medicare prescriptions for Brimonidine Tartrate-Timolol, about the same volume as the typical California prescriber of this medication (26). Medicare paid an average of $243.51 per fill, versus $285.63 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 39.1 30-Day Fills standardized to 30-day supplies 1,123 Days of Medication total across all patients in 2023 | |||
| AzoptBrinzolamide | 24 | $412.31▼ below CA avg | ▼ Less than typical |
About Azopt: Brinzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 24 Medicare prescriptions for Azopt, about 69% of the volume of the typical California prescriber of this medication (35). Medicare paid an average of $412.31 per fill, versus $457.37 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 31.2 30-Day Fills standardized to 30-day supplies 937 Days of Medication total across all patients in 2023 | |||
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 23 | $12.80▼ below CA avg | ▼ Less than typical |
About Neomycin-Polymyxin-Dexameth: This medication is used to treat conditions involving swelling (inflammation) of the eyes and to treat or prevent bacterial eye infections. Show more ▾ This product contains neomycin and polymyxin, antibiotics that work by stopping the growth of bacteria. It also contains dexamethasone, an anti-inflammatory corticosteroid that works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections and may worsen them (such as infections caused by viruses, fungi, mycobacteria). Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. In 2023, this provider wrote 23 Medicare prescriptions for Neomycin-Polymyxin-Dexameth, about half the volume of the typical California prescriber of this medication (41). Medicare paid an average of $12.80 per fill, versus $14.80 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 25 30-Day Fills standardized to 30-day supplies 292 Days of Medication total across all patients in 2023 | |||
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 22 | $72.46▼ below CA avg | ▼ Less than typical |
About Tobramycin-Dexamethasone: This medication is used to treat or prevent eye infections. Show more ▾ This medication contains two drugs. Tobramycin belongs to a class of drugs called aminoglycoside antibiotics. It works by stopping the growth of bacteria. Dexamethasone belongs to a class of drugs called corticosteroids. It works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. A topical preparation of tobramycin and dexamethasone that is used for treating or preventing superficial bacterial infections of the eye. In 2023, this provider wrote 22 Medicare prescriptions for Tobramycin-Dexamethasone, about half the volume of the typical California prescriber of this medication (41). Medicare paid an average of $72.46 per fill, versus $84.01 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 25.3 30-Day Fills standardized to 30-day supplies 474 Days of Medication total across all patients in 2023 | |||
| Cosopt PfDorzolamide/Timolol/Pf | 21 | $252.39▼ below CA avg | ≈ Typical |
About Cosopt Pf: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 21 Medicare prescriptions for Cosopt Pf, about the same volume as the typical California prescriber of this medication (23). Medicare paid an average of $252.39 per fill, versus $286.52 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 27 30-Day Fills standardized to 30-day supplies 810 Days of Medication total across all patients in 2023 | |||
| Doxycycline Hyclate | 20 | $30.21▼ below CA avg | ▼ Less than typical |
About Doxycycline Hyclate: This medication is used to treat a wide variety of bacterial infections, including those that cause acne. Show more ▾ This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A synthetic tetracycline derivative with similar antimicrobial activity. In 2023, this provider wrote 20 Medicare prescriptions for Doxycycline Hyclate, about 74% of the volume of the typical California prescriber of this medication (27). Medicare paid an average of $30.21 per fill, versus $30.50 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 27.4 30-Day Fills standardized to 30-day supplies 645 Days of Medication total across all patients in 2023 | |||
| Difluprednate | 19 | $131.53▼ below CA avg | ▼ Less than typical |
About Difluprednate: This medication is used to treat swelling and pain after eye surgery. Show more ▾ It may also be used to treat a certain serious eye problem (endogenous anterior uveitis). This medication belongs to a class of drugs known as corticosteroids. In 2023, this provider wrote 19 Medicare prescriptions for Difluprednate, about half the volume of the typical California prescriber of this medication (42). Medicare paid an average of $131.53 per fill, versus $160.49 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 19 30-Day Fills standardized to 30-day supplies 482 Days of Medication total across all patients in 2023 | |||
| MoxifloxacinMoxifloxacin Hcl | 19 | $29.05▼ below CA avg | ▼ Less than typical |
About Moxifloxacin: This medication is a quinolone antibiotic used for eye infections. Show more ▾ A fluoroquinolone that acts as an inhibitor of DNA TOPOISOMERASE II and is used as a broad-spectrum antibacterial agent. In 2023, this provider wrote 19 Medicare prescriptions for Moxifloxacin, about 19% of the volume of the typical California prescriber of this medication (99). Medicare paid an average of $29.05 per fill, versus $35.22 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 19 30-Day Fills standardized to 30-day supplies 257 Days of Medication total across all patients in 2023 | |||
| Cyclosporine | 19 | $359.40▼ below CA avg | ▼ Less than typical |
About Cyclosporine: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. In 2023, this provider wrote 19 Medicare prescriptions for Cyclosporine, about half the volume of the typical California prescriber of this medication (32). Medicare paid an average of $359.40 per fill, versus $516.93 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 35 30-Day Fills standardized to 30-day supplies 1,035 Days of Medication total across all patients in 2023 | |||
| VyzultaLatanoprostene Bunod | 16 | $329.13▼ below CA avg | ▼ Less than typical |
About Vyzulta: Latanoprostene bunod is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by controlling the flow of fluid within the eye to maintain a normal pressure. In 2023, this provider wrote 16 Medicare prescriptions for Vyzulta, about a quarter of the volume of the typical California prescriber of this medication (63). Medicare paid an average of $329.13 per fill, versus $398.80 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 20 30-Day Fills standardized to 30-day supplies 467 Days of Medication total across all patients in 2023 | |||
| Epinastine Hcl | 14 | $97.57 | ▼ Less than typical |
About Epinastine Hcl: This medication is an antihistamine used to prevent itching of the eyes caused by allergies (allergic conjunctivitis). In 2023, this provider wrote 14 Medicare prescriptions for Epinastine Hcl, about half the volume of the typical California prescriber of this medication (33). Medicare paid an average of $97.57 per fill, versus $91.71 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 18.7 30-Day Fills standardized to 30-day supplies 537 Days of Medication total across all patients in 2023 | |||
| ErythromycinErythromycin Base | 14 | $11.11▼ below CA avg | ▼ Less than typical |
About Erythromycin: Erythromycin is used to treat a wide variety of bacterial infections. Show more ▾ It may also be used to prevent certain bacterial infections. Erythromycin is known as a macrolide antibiotic. It works by stopping the growth of bacteria. This antibiotic treats or prevents only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. In 2023, this provider wrote 14 Medicare prescriptions for Erythromycin, about a third of the volume of the typical California prescriber of this medication (50). Medicare paid an average of $11.11 per fill, versus $15.82 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 14 30-Day Fills standardized to 30-day supplies 131 Days of Medication total across all patients in 2023 | |||
| Loteprednol Etabonate | 12 | $244.91 | ▼ Less than typical |
About Loteprednol Etabonate: This medication is used to temporarily relieve seasonal allergy symptoms of the eyes such as swelling, redness, and itching. Show more ▾ Loteprednol belongs to a class of drugs known as corticosteroids. An androstadiene derivative corticosteroid that is used as an ANTI-ALLERGIC AGENT for the treatment of inflammatory and allergic eye conditions. In 2023, this provider wrote 12 Medicare prescriptions for Loteprednol Etabonate, about a third of the volume of the typical California prescriber of this medication (29). Medicare paid an average of $244.91 per fill, versus $215.54 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 15 30-Day Fills standardized to 30-day supplies 394 Days of Medication total across all patients in 2023 | |||
| Travoprost | 11 | $214.30▼ below CA avg | ▼ Less than typical |
About Travoprost: Travoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol derivative that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 11 Medicare prescriptions for Travoprost, about a third of the volume of the typical California prescriber of this medication (35). Medicare paid an average of $214.30 per fill, versus $232.53 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 17 30-Day Fills standardized to 30-day supplies 455 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for MRS. AVNEET KAUR SODHI-GAUR M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Ophthalmology prescribing approach at this Lancaster, CA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among CA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
